JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

JNJ

170.73

-0.23%↓

NVS

117.78

-0.02%↓

ABT

130.77

+0.52%↑

TMO

466.56

-0.22%↓

ISRG

476.87

-1.3%↓

Search

NeoGenomics Inc

Cerrado

5.62 -0.88

Resumen

Variación precio

24h

Actual

Mínimo

5.54

Máximo

5.86

Métricas clave

By Trading Economics

Ingresos

-19M

-45M

Ventas

13M

181M

Margen de beneficios

-24.867

Empleados

2,200

EBITDA

-41M

-48M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+63.84% upside

Dividendos

By Dow Jones

Próximas Ganancias

4 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-99M

732M

Apertura anterior

6.5

Cierre anterior

5.62

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

NeoGenomics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 16:50 UTC

Principales Movimientos del Mercado

Verb Technology Shares Double After Private Placement, Intent to Buy Cryptocurrency

31 jul 2025, 20:58 UTC

Ganancias

Coinbase Global Misses on 2Q Revenue, Outlook

31 jul 2025, 20:37 UTC

Ganancias

MicroStrategy Swings to 2Q Profit on Bitcoin Gains

29 jul 2025, 17:53 UTC

Principales Movimientos del Mercado

ZOOZ Shares Down; Plans $180 Million Private Placement for Bitcoin Reserve Strategy

29 jul 2025, 16:36 UTC

Principales Movimientos del Mercado

Antelope Enterprise Shares Drop After Securities Purchase Agreement

5 ago 2025, 13:55 UTC

Charlas de Mercado

Bitcoin Is Being Treated as a Portfolio Diversifier -- Market Talk

5 ago 2025, 08:43 UTC

Charlas de Mercado

Market Talk Roundup: Latest on U.S. Politics

5 ago 2025, 08:43 UTC

Charlas de Mercado

Bitcoin Eases Amid Tariff Uncertainty -- Market Talk

4 ago 2025, 08:37 UTC

Charlas de Mercado

Bitcoin Recovers as U.S. Rate-Cut Bets Rise -- Market Talk

1 ago 2025, 22:31 UTC

Ganancias

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

1 ago 2025, 08:22 UTC

Charlas de Mercado

Bitcoin Falls to Three-Week Low After Tariff News, Ahead of U.S. Data -- Market Talk

31 jul 2025, 21:26 UTC

Ganancias

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 jul 2025, 20:43 UTC

Ganancias

Riot Platforms 2Q Produced 1,426 Bitcoin, as Compared to 844 During the Same 3-Mo Period in 2024 >RIOT

31 jul 2025, 20:43 UTC

Ganancias

Riot Platforms 2Q Rev $153M >RIOT

31 jul 2025, 20:31 UTC

Ganancias

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31 jul 2025, 15:30 UTC

Ganancias

What MicroStrategy Earnings Tell Us About the Current State of Crypto Mania -- Barrons.com

31 jul 2025, 15:20 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Coinbase Reports Earnings This Afternoon. What to Watch. -- Barrons.com

31 jul 2025, 07:36 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

31 jul 2025, 07:36 UTC

Charlas de Mercado

Bitcoin Modestly Higher But Stays Below Key $120,000 Level -- Market Talk

30 jul 2025, 07:28 UTC

Charlas de Mercado

Bitcoin Edges Higher But Remains Stuck in a Range -- Market Talk

29 jul 2025, 21:45 UTC

Charlas de Mercado
Ganancias

Visa Views Stablecoin as Growth Opportunity -- Market Talk

29 jul 2025, 21:21 UTC

Ganancias

Visa CEO: U.S. Spend Growth Remained Strong in 2Q, No Noticeable Effects From Tariff

29 jul 2025, 21:19 UTC

Ganancias

Visa CEO: Consumers Have Used Visa to Spend $25B in Cryptocurrencies Since 2020

29 jul 2025, 21:17 UTC

Ganancias

Visa Is Best Way to Spend Money Using Stablecoins, CEO Says

29 jul 2025, 21:17 UTC

Ganancias

Visa CEO: We Support Genius Act, Believe Stablecoins Can Solve Problems for Certain Use Cases

29 jul 2025, 17:38 UTC

Principales Movimientos del Mercado

ZOOZ Shares Down; Plans $180M Private Placement for Bitcoin Reserve Strategy

29 jul 2025, 14:05 UTC

Ganancias

SoFi Stock Pops on Outlook Raise as Members Keep Piling In -- Update

29 jul 2025, 12:09 UTC

Charlas de Mercado

Stablecoin Regulation Could Support Dollar -- Market Talk

29 jul 2025, 09:43 UTC

Charlas de Mercado

Ethereum Could Rise Further on Corporate Treasury Purchases -- Market Talk

29 jul 2025, 08:24 UTC

Charlas de Mercado

Bitcoin Rises Slightly After U.S.-EU Trade Deal -- Market Talk

Comparación entre iguales

Cambio de precio

NeoGenomics Inc previsión

Precio Objetivo

By TipRanks

63.84% repunte

Estimación a 12 Meses

Media 9.29 USD  63.84%

Máximo 12 USD

Mínimo 8 USD

De acuerdo con 11 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para NeoGenomics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

11 ratings

4

Comprar

7

Mantener

0

Vender

Puntuación técnica

By Trading Central

7.7 / 10.27Soporte y Resistencia

Corto Plazo

Very Strong Bearish Evidence

Medio plazo

Bearish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.